As Roche Explores Using 454 Platform for HLA Typing, Some US Labs Remain Cautious
March 17, 2009
As Roche Explores Using 454 Platform for HLA Typing, Some US Labs Remain Cautious
By Julia Karow
454 says some of its customers outside the US are close to using the GS FLX for clinical HLA typing. It is also working with the FDA to find ways to provide the tool to US testing labs, some of which doubt it is robust and cheap enough for such use.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.